Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2001

01-01-2001

Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States)

Authors: Vicki B. Benard, Nancy C. Lee, Margaret Piper, Lisa Richardson

Published in: Cancer Causes & Control | Issue 1/2001

Login to get access
Metadata
Title
Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States)
Authors
Vicki B. Benard
Nancy C. Lee
Margaret Piper
Lisa Richardson
Publication date
01-01-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 1/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008959019019

Other articles of this Issue 1/2001

Cancer Causes & Control 1/2001 Go to the issue

OriginalPaper

Chordoma: incidence and survival patterns in the United States, 1973–1995

Legacy

Addressing class-based disparities related to tobacco: working with labor unions

OriginalPaper

Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies

OriginalPaper

Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening

OriginalPaper

Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case–control study in Sudan

OriginalPaper

Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits